Palmaz Scientific holds nearly 100 issued patents and has over 100 active patent filings under review by U.S. and international patent offices. Palmaz Scientific's strategy is to commercialize the Palmaz Nanotechnology Platform through the introduction of products, third party licensing, funded development, joint ventures or other strategic partnerships. The commercialization effort will be supported by brand awareness campaigns, establishment of a thought leadership advisory board, patent expansion and protection, and collaborative relationships with leading medical institutions of higher education.
Palmaz Scientific is currently developing or reviewing applications in a number of areas discovered through its own research and development as well as through ideas generated by others that leverage Palmaz Scientific innovations.